Top Markets
Coin of the day
PRISM BioLab Co.,LTD PRISM BioLab Co.,LTD

PRISM BioLab Co.,LTD

206A
Rang in Aktien #26417
PRISM Pharma Co., Ltd. is a pharmaceutical enterprise dedicated to identifying... PRISM Pharma Co., Ltd. is a pharmaceutical enterprise dedicated to identifying and advancing small molecule compounds. Its core mission involves modulating protein-protein interactions. The company leverages a proprietary protein secondary structure mimetic library to regulate interactions between proteins within cells. A key product in its development pipeline is PRI-724, an anti-cancer CP/Catenin inhibitor. This drug targets both mature cancer cells and cancer stem cells, inducing them to transition from uncontrolled proliferation to differentiation. Hiroyuki Kouji founded the organization on November 2, 2006, and it is headquartered in Fujisawa, Japan.
Aktienkurs
$1.10
Marktkapitalisierung
$40.76M
Veränderung (1 Tag)
3.68%
Veränderung (1 Jahr)
-13.12%
Land
JP
Handel PRISM BioLab Co.,LTD (206A)

Kategorie

Kursverlauf für PRISM BioLab Co.,LTD (206A)
Höchster Schlusskurs: $1.09 am 2026-08-01

Niedrigster Schlusskurs: $3.37 am 2024-07-01
Kursverlauf der Aktie von PRISM BioLab Co.,LTD von 2024 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 5.01%
2025 -46.32%
2024 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$546.54 38.59%
US
$1.04K 56.71%
NL
$120.74 -14.98%
AU
$138.98 416.85%
US
$761.87 7.04%
CH